Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A van den Bos

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Beta blockade in neurocardiogenic dysfunction: results of a clinical studyM R P Baselier, A A van den Bos
Chest|September 1, 1978
Progressive development of a left ventricular thrombusA A van den Bos, W B Vletter, F Hagemeijer
Catheterization and Cardiovascular Diagnosis|February 1, 1997
A new thrombosuction catheter for coronary use: initial results with clinical and angiographic follow-up in seven patientsA A van den Bos, V van Ommen, H M Corbeij
The American Journal of Cardiology|December 15, 1993
Usefulness of repeat coronary angiography 24 hours after successful balloon angioplasty to evaluate early luminal deterioration and facilitate quantitative analysisD P Foley, J Deckers, A A van den Bos, et al.
The American Journal of Cardiology|April 15, 1997
Removal of thrombus from aortocoronary bypass grafts and coronary arteries using the 6Fr HydrolyserV G van Ommen, A A van den Bos, M Pieper, et al.
The New England Journal of Medicine|September 21, 1995
A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica InvestigatorsP W Serruys, J P Herrman, R Simon, et al.
Circulation|November 1, 1993
Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplastyA A van den Bos, J W Deckers, G R Heyndrickx, et al.
International Journal of Cardiology|February 15, 2005
Fluvastatin reduces the 4-year cardiac risk in patients with multivessel diseasePedro A Lemos, Pim J de Feyter, Patrick W Serruys, et al.
European Heart Journal|July 1, 1995
Angiographic dose-finding study with r-hirudin (HBW 023) for the improvement of thrombolytic therapy with streptokinase (HIT-SK). Interim resultsG P Molhoek, G J Laarman, D J Lok, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Beta blockade in neurocardiogenic dysfunction: results of a clinical studyM R P Baselier, A A van den Bos
Chest|September 1, 1978
Progressive development of a left ventricular thrombusA A van den Bos, W B Vletter, F Hagemeijer
Catheterization and Cardiovascular Diagnosis|February 1, 1997
A new thrombosuction catheter for coronary use: initial results with clinical and angiographic follow-up in seven patientsA A van den Bos, V van Ommen, H M Corbeij
The American Journal of Cardiology|December 15, 1993
Usefulness of repeat coronary angiography 24 hours after successful balloon angioplasty to evaluate early luminal deterioration and facilitate quantitative analysisD P Foley, J Deckers, A A van den Bos, et al.
The American Journal of Cardiology|April 15, 1997
Removal of thrombus from aortocoronary bypass grafts and coronary arteries using the 6Fr HydrolyserV G van Ommen, A A van den Bos, M Pieper, et al.
The New England Journal of Medicine|September 21, 1995
A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica InvestigatorsP W Serruys, J P Herrman, R Simon, et al.
Circulation|November 1, 1993
Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplastyA A van den Bos, J W Deckers, G R Heyndrickx, et al.
International Journal of Cardiology|February 15, 2005
Fluvastatin reduces the 4-year cardiac risk in patients with multivessel diseasePedro A Lemos, Pim J de Feyter, Patrick W Serruys, et al.
European Heart Journal|July 1, 1995
Angiographic dose-finding study with r-hirudin (HBW 023) for the improvement of thrombolytic therapy with streptokinase (HIT-SK). Interim resultsG P Molhoek, G J Laarman, D J Lok, et al.
Pageof 1